Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Bristol-Myers Squibb (BMS) building

BMS’ Yervoy receives additional FDA approval

Gives the nod for Yervoy as adjuvant treatment option for melanoma

- PMLiVE

Synergy Vision in Asia-Pacific push

New Sydney office willbe headed up by Corinne Whitehead

- PMLiVE

PBMs drop Philidor, and Valeant follows suit

Comes after allegations of impropriety

- PMLiVE

Allergan/Pfizer takeover talks confirmed

Talks still in early stage with no certainty of deal

- PMLiVE

FDA approves Merrimack’s pancreatic cancer drug

Onivyde improves overall survival rates

Asana appoints new chief medical officer

Louis Denis joins from Boehringer Ingelheim

- PMLiVE

Baxter appoints Jose Almeida chairman and CEO

Will take over from Robert Parkinson Jr in Janary

- PMLiVE

Novartis’ Cosentyx off to a flyer in psoriasis

Year-to-date sales reach $140m for recently approved drug

- PMLiVE

FDA approves Janssen’s Yondelis

Provides additional treatment option for softtissue sarcoma

- PMLiVE

Merck and MacroGenics collaborate on immuno-oncology

Evaluates margetuximab with Keytruda for gastric cancer

- PMLiVE

Is Pfizer eyeing a merger with Allergan?

Combined company value could be $330bn

- PMLiVE

Jane Osbourn to chair BIA board

VP of R&D atMedimmune to chair BioIndustry Association board

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links